During the past decade, Retina Macula Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Macula Institute" #1 collaborator was "Allergan" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Retina Macula Institute" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (1 trials), "Macular Edema" (1 trials), "Neovascular Age Related Macular Degeneration" (1 trials) and "Non-Infectious Uveitis" (1 trials). Many other conditions were trialed in "Retina Macula Institute" in a lesser frequency.

Most popular intervention types in "Retina Macula Institute" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (2 trials), "Efalizumab" (1 trials), "FAI insert" (1 trials), "Lampalizumab" (1 trials) and "OCT, Multifocal ERG, Microperimetry" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Macula Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Retina Macula Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Retina Macula Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Macula Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".